Poly methacrylic acid modified CDHA nanocomposites as potential pH responsive drug delivery vehicles

Add time:07/26/2019    Source:sciencedirect.com

The objective of this study was to prepare pH sensitive polymethacrylic acid-calcium deficient hydroxyapatite (CDHA) nanocomposites. The CDHA nanoparticles were prepared by coprecipitation method. The modification of CDHA by methacrylic acid (MA) was achieved by AIBN initiated free radical polymerization with sodium bisulphite as catalyst followed by emulsion technique. These nanocomposites with a half life of 8 h consisted of high aspect ratio, needle like particles and exhibited an increase in swelling behaviour with pH. The in vivo potential of the nanocomposites was evaluated in vitro by the results of cell aggregation, protein adsorption, MTT assay and haemolytic activity. The invitro loading and release studies using albumin as a model drug indicate that the nanocomposites gave better loading when compared to the CDHA nanoparticles and altered the drug release rates. The nanocomposites also exhibited good uptake on C6 glioma cells as studied by fluorescence microscopy. The results obtained suggest that these nanocomposites have great potential for oral controlled protein delivery and can be extended further for intracellular drug delivery applications.

We also recommend Trading Suppliers and Manufacturers of METHACRYLIC ACID CALCIUM SALT (cas 16809-88-4). Pls Click Website Link as below: cas 16809-88-4 suppliers

Prev:Schizophrenic micellization of poly(ethylene oxide-b-methacrylic acid) induced by phosphate and calcium ions
Next:Development and in vitro evaluation of thiolated chitosan—Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system)